Europe Drug Delivery Devices Market: By Product Type (Infusion Pumps, Metered Dose Inhalers, Nebulizers, Syringes, Ocular Inserts, Nasal Sprays, Implantable Drug Delivery Devices, Transdermal Patches, Trans-Mucosal Drug Delivery Devices, Others), By Route of Administration (Oral, Parenteral, Transdermal, Trans-Mucosal, Inhalation, Ocular, Others), By Formulation (Solid, Liquid, Semi-Solid), By Application (Diabetes, Oncology, Autoimmune Disorders, Neurological Disorders, Gastrointestinal Disorders, Respiratory Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Geography    

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

Europe Drug Delivery Devices Market size was valued at USD 360.0 billion in 2021 and is expected to reach USD 537.7 billion by 2028, at a CAGR of 5.9% during the forecast period 2022 to 2028. Drug delivery devices are used to deliver the drugs or chemical substances into the body for therapeutic effects by using different formulations, technologies, and approaches. These devices can be used for diagnosis, treatment, cure, or prevent various diseases such as diabetes, autoimmune disorders, bacterial and viral infections, and allergies among others. Various medicinal formulations such as antibiotics and insulin are most commonly administered by using these devices to increase the efficiency of drug by controlling dosage, time, and release the drug at specific site in the body.

Europe Drug Delivery Devices Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Europe Drug Delivery Devices Market Dynamics

Drivers: Increase in the prevalence of chronic diseases such as diabetes and cancer due to change in lifestyle Rise in R&D activities for the innovation of newer devices Rise in demand for customized therapy and better availability of the products Restraints: Stringent regulation for the approval of drug delivery devices Product recalls and Complications in the use of drug delivery devices such as dosage errors High cost of drug delivery devices

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Europe Drug Delivery Devices Market Segmentation

By Product Type
  • Infusion Pumps
  • Metered Dose Inhalers
  • Nebulizers
  • Syringes
  • Ocular Inserts
  • Nasal Sprays
  • Implantable Drug Delivery Devices
  • Transdermal Patches
  • Trans-Mucosal Drug Delivery Devices
  • Others
Route Administration
  • Oral
  • Parenteral
  • Transdermal
  • Trans-Mucosal
  • Inhalation
  • Ocular
  • Others
formulation type
  • Solid
  • Liquid
  • Semi-solid
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Becton Dickinson and Company (U.S.)
  • Hoffmann La Roche Ltd. (Switzerland)
  • Smiths medical, Inc. (U.S.)
  • Braun Melsungen AG (Germany)
  • Pfizer, Inc. (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Sanofi S.A. (France)
  • Abbott Laboratories (U.S.)
  • Novartis AG (Switzerland)
  • Eli Lilly and company (U.S.)
  • AptarGroup, Inc. (U.S.)